This study assessed first the impact of endometrial Tiam1/ Rac1 signals and microRNA-22 (miR-22) on embryo implantation in mice, and then the expression of the above three genes in the endometrium during the embryo implantation window in the natural menstrual cycle in women with repeated implantation failure (RIF) after in vitro fertilization treatment. Four hundred fifty-two Kun-ming female mice and 200 women (70 infertility patients with RIF, 130 women as controls) were entered into this study. Endometrial Tiam1/Rac1 signals and miR-22 expression were studied in clinical and mouse samples and serum estrogen (E 2 ) and progesterone (P) were analyzed in clinical subjects. A pregnant mouse model based on an endometrial miR-22 and Tiam1 mRNA expression trend of patients with RIF was constructed and then the embryo implantation numbers were analyzed, and an ovariectomized mouse model was used to assess correlations of expression of these three genes with E 2 and P. The results showed that during the embryo implantation window in the natural menstrual cycle, endometrial miR-22 was significantly higher whereas Tiam1/Rac1 signals were notably lower in patients with RIF than in controls, and the P:E 2 ratio was statistically lower in the RIF group. Tiam1/Rac1 signal down-regulation and miR-22 up-regulation contributed to the inhibition of embryo implantation in mice. We also found a suppressive effect of miR-22 up-regulation on Tiam1/Rac1 signal expression, and reciprocal regulation of E 2 and P for these three genes' expression in mice. In conclusion, miR-22 up-regulation and Tiam1/Rac1 signal down-regulation inhibited embryo implantation in mice; this mechanism may be partially due to the suppressive effect of miR-22 on Tiam1 expression, and is regulated to some extent by serum E 2 and P. Our findings provide evidence that endometrial Tiam1/Rac1 signal downregulation along with miR-22 up-regulation during embryo implantation window in the natural menstrual cycle may be one of the reasons for the failure of embryo implantation in patients with RIF.
INTRODUCTION
At present, repeated implantation failure (RIF) caused by various etiological agents remains a challenge for fertility clinicians using assisted reproduction technology (ART) worldwide, although some treatments (such as uterine septectomy; removal of intrauterine adhesions; endometrial polypectomy or myomectomy, particularly the submucous type; excision of hydrosalpinx; mechanical stimulation; and so on) have been beneficial for women with RIF [1] . RIF may be caused by multiple factors such as embryo quality and endometrium receptivity [1] [2] [3] [4] . It has been reported that failure of more than three cycles that transferred good embryos in in vitro fertilization-embryo transfer (IVF-ET) is caused by an undiagnosed uterine pathology, and that improper expression of critical genes in the endometrium during the implantation window inhibits embryo implantation [2, 3, 5] . This may account for a major proportion of the low pregnancy rates in patients with RIF.
Our previous studies demonstrated that T-lymphoma invasion and metastasis inducing factor 1 (Tiam1) was spatiotemporally expressed in the endometrium of estrous and early pregnant mice and was involved in regulating stromal cell decidualization, endometrial receptivity attainment, and embryo implantation in mice [6] [7] [8] . Another study reported that human embryo implantation required Rasrelated C3 botulinum toxin substrate 1 (RAC1)-dependent endometrial stromal cell migration [9] . It is well known that Tiam1, as a specific guanine exchange factor for Rac1, could activate Rac1 and then regulate cytoskeleton restructuring, cell migration, motility, adhesion, and dynamic cellular processes in a variety of cell types [10] [11] [12] [13] [14] [15] . MicroRNA-22 (miR-22) is found to negatively regulate the function of Tiam1 by inhibiting Tiam1 mRNA transcription and translation in some tumor cells [16, 17] . Several studies showed that expression of some genes might be downregulated by miRNAs in the secretory phase of the endometrium, and the aberrant expression profile of miRNAs has been associated with defective endometrial receptivity in humans [1, [18] [19] [20] . Patients with RIF have a special endometrial gene expression profile during embryo implantation, and the gene expression pathology of achieving endometrial receptivity for patients suffering from RIF remains unclear [4, 21, 22] . This study aimed to investigate the effect of endometrial miR-22 and Tiam1/Rac1 signals on embryo implantation in mice and analyzed the correlations of the expression of miR-22, Tiam1, and Rac1 with serum estrogen (E 2 ) and progesterone (P). This study also assessed the expression of miR-22 and TIAM1/RAC1 signals in the endometrium in the natural menstrual cycle in patients with RIF after IVF treatment.
MATERIALS AND METHODS

Animal Model
Six-to eight-week-old mice of the Kun-ming breed were obtained from the Laboratory Animal Center of Xiangya Medical Central South University. The experimental procedures of the study were in accordance with the policy of the Ethics Committee, Reproductive Biology Laboratory, Animal Association, and the Chinese Academy of Sciences and approved by the Institution Animal Use and Care Committee, Central South University.
Kun-ming breed female mice were kept under optimal conditions of hygiene, temperature, and humidity with a 12L:12D cycle and were allowed food and water ad libitum. With the two-to-one ratio, two female mice were allowed to mate with one intact or vasectomized male mouse from 1900 h to 0700 h and then checked for the presence of vaginal plug at 0700 h. The day of vaginal plug was considered to be Day 1 of pregnancy or pseudopregnancy of mice. Fourteen female estrous mice were used for the control group. According to the day of pregnancy or pseudopregnancy, mice were killed at 1900-2000 h on Days 2-7, 15 mice per day. All mice endometria were scraped by curved needle and stored in À808C for further experiments.
E 2 and P Administration Model in Ovariectomized Mice
According to the method of Tan and Quan [23] , Salgado et al. [24] , and Yu [25] , 90 6-to 8-wk-old female mice of the Kun-ming breed, weight 30-35 g, underwent intraperitoneal injection of 10% chloral hydrate (0.005 ml/g dose), and were anesthetized after 20 min. The mouse abdomens were upward, shaved, and 75% alcohol disinfected, and then a 1-cm incision was made in the abdomen with scissors and exposure of intraperitoneal tissue was performed under a microscope. The ovary and oviduct were then removed from the abdominal cavity; the uterus was clamped and returned to the abdominal cavity. Finally, the abdominal cavity was closed. The same method of resection was carried out for the right ovary. Ovariectomized mice were allowed to recover from the surgery for 17 days, enough time for the residual E 2 and P to be completely metabolized. The mice then were randomly allocated for the subsequent experiments.
Ovariectomized mice were randomized into four subgroups: untreated negative control group (n ¼ 10), E 2 plus progestin combination administration group (estradiol valerate 1 mg þ medroxyprogesterone acetate 2 mg, n ¼ 10), E 2 administration group (n ¼ 30), and progestin administration group (n ¼ 30) The latter two groups were randomly divided into three subgroups of 10 mice. The E 2 administration group was divided into three dose-gradient groups of estradiol valerate (Bayer Corporation) at 0.25, 0.5, and 1 mg, respectively. The progestin-administered group was divided into three dose-gradient subgroups of medroxyprogesterone acetate (Xianju Pharma Limited Company) at 0.5, 1, and 2 mg, respectively, and intragastric administration was performed by mouth according to the method of Salgado et al. [24] and Yu [25] , with continuous administration for 7 days. Laparotomy was then performed to collect the endometria that were subsequently stored at À808C.
Tiam1 RNAi and miR-22 Overexpression Mice Model
LV3-miR-22 (R2012-89SH, miR-22 overexpression lentiviral) and LV3-Tiam1-shRNA (GR391, Tiam1 RNAi lentiviral) lentivirus recombinant plasmid and LV3-NC lentivirus plasmid (HPC003, lentivirus not containing the target gene) were constructed and packaged with green fluorescent protein (GFP; Shanghai GenePharma Co., Ltd.). The lentiviral sequences are shown in Table 1 . One hundred eighty eugamic female mice were randomly allocated to four groups, including the control group without any intervention, the LV3 group, the LV3-miR-22 group, and the LV3-Tiam1-shRNA group, 50 mice per group. For uterus injection of the virus, mice were anesthetized with 6% chloral hydrate (0.5 ml/100 g) via intraperitoneal injection, then positioned in a stereotaxic instrument, and 12 ll LV3-miR-22, LV3-Tiam1-shRNA, or LV3 solution (1 3 10 9 IU/ml) was injected into the uterus with multipoint injection at a rate of 1 ll/min according to the previously described lentiviral injection method in vivo [26] [27] [28] [29] [30] . The manual microsyringe was left in place for 1 min before being slowly withdrawn from the uterus. Tenmillimeter-thickness cryosections of mice uteri were made on the third, fifth, sixth, seventh, and eighth days after lentiviral injection, and then the fluorescent signals of GFP in each cryosection were investigated by a fluorescence microscope. For detecting transfection efficiency, the suppression of Tiam1 mRNA expression and the overexpression of miR-22 were analyzed by quantitative real-time PCR (qRT-PCR), and TIAM1 and RAC1 protein levels were detected by Western blot on the day the fluorescent signals appeared after lentiviral injection in vivo.
miR-22 and Tiam1 Functional Analysis in the Endometrium During Embryo Implantation
After successful lentiviral transfection was confirmed by testing transfection efficiencies with qRT-PCR and Western blot, the transfected female mice were mated with male mice. The day of vaginal plug was considered to be Day 1 of pregnancy. Fifteen mice in each group were killed on the fourth day of pregnancy (embryo implantation window), and then the endometria were collected to measure miR-22, Tiam1, and Rac1 mRNA expression by qRT-PCR (n ¼ 5), and uterus protein was extracted to analyze TIAM1 and RAC1 protein expression by Western blot analysis (n ¼ 5) and immunohistochemistry analysis (n ¼ 5). In order to identify embryo implantation sites in uterine horns, at 1900-2000 h on the fifth day of pregnancy, five mice in each group were injected with 500 ll of 0.4% (w/v) trypan blue dye into the tail vein according to the method of Psychoyos [31] and Fouladi-Nashta [32] . After 10 min, these animals were killed and the intensity of the blue bands around the implantation sites was measured and recorded.
Human Subject and Endometrial Sampling
The patients in this study were recruited from June to October 2010 from the IVF unit of the Reproductive & Genetic Hospital of Citic-Xiangya as shown in Figure 1 . All women in this study were 22;35 yr old, with a body mass index (BMI) of 18-25 kg/m 2 , menstrual regularity at 26-33-day period, and endometrium thickness of 8;14 mm during the late proliferation phase (LPP) as detected by B ultrasound (BUS) in their natural menstrual cycle. Patients with hydrosalpinx, myoma of uterus, endometrial polyps, tuberculosis and inflammation, endometriosis, or polycystic ovary syndrome were excluded. Patients were also excluded for other pathological conditions such as karyotypic abnormalities and any inherited diseases, thyroid function abnormality, prolactinoma, and other endocrine diseases. The subjects were instructed not to use hormone therapy during the research period. According to follicle diameter and ovulation by BUS in their natural menstrual cycle, all subjects were allocated to different phase groups, including the early proliferation phase group (EPP; follicle diameter was limited to ,10 mm), the LPP group (follicle diameter !18 mm), the early secretion phase group (ESP; the third day after ovulation), the middle secretion phase group (MSP, from the seventh to the ninth day after ovulation), and the late secretion phase group (LSP, from the 12th to the 13th day after ovulation). All subjects in this study underwent measurement of endometrium thickness and follicle diameter and ovulation by BUS. The endometrium was sampled by a disposable endometrium sampler (Pipelle Mark II, Laboratoire CCD s.a.s.) at the given time points and 2 ml venous blood was collected on the day of endometrium sampling for assaying serum estradiol (E 2 ) and P levels by radioimmunoassay. Only one sampling was performed for each subject.
Seventy women with RIF were divided into five groups: EPP, LPP, ESP, MSP, and LSP, with 14 patients per group. The patients with RIF had a good ovary reserve (follicle-stimulating hormone ,8 mIU/ml, 5;12 antral follicle count per ovary), a good response to hormonal stimulation (more than eight oocytes/oocyte retrieval), and a normal uterine cavity without intrauterine adhesion confirmed by hysteroscopy. No fewer than six high-quality embryos were transferred in total for patients with RIF in the study group who had been through at least three ET failures. One hundred fifty-eight acquired infertile patients with fallopian tube obstruction (diagnosed by hysterosalpingography) and at least one normal pregnancy and/or delivery were recruited in this study. They were allocated to five groups: EPP, LPP, ESP, MSP, and LSP. Endometrium thickness, follicle diameter, and ovulation were measured in all patients by BUS and endometrium tissue was collected by disposable endometrium sampler at the given time. One hundred thirty of them who acquired pregnancy or delivery in late IVF-ET cycle after sampling and entered the control group were analyzed in this study, 26 patients per phase.
Ethical Approval
All participants signed informed consent forms following the approval of the institutional ethics committee of Central South University (number LLSC062).
Quantitative Real-Time RT-PCR
The endometrial RNA from both humans and mice was extracted by using Trizol reagent according to the manufacturer's instructions. The reverse transcription reaction was carried out and then cDNAs were stored at À808C. The sequences of the primers for qRT-PCR are shown in Table 2 . Quantification of the transcripts was carried out in the ABI Prism 7000 HT.
Western Blot Analysis
Endometrial tissue samples were lysed in cell lysis buffer, homogenated, and then centrifuged to collect proteins. Total protein sample was loaded onto an SDS-PAGE gel. Following electrophoresis, the proteins were transferred to polyvinylidene fluoride (PVDF) membranes and blocked in Tris-buffered FIG. 1. The recruitment of clinical subjects. RIF, RIF patients; control, control women; Allocated, according to the patient's willingness and convenience time for sampling the patients were pointed into different phase groups; Lost, Lost to follow-up, means that patients missing the sampling schedule, or for whom endometrial polyps or other problems were detected by B-ultra sonography before sampling, were not sampled and followed up; Excluded, excluded from analysis, means that patients whose sampled endometrium was too little or no sample was taken or without pregnancy in later IVF cycle after sampling for control women were excluded in this study. *Only 14 cases of LPP and MSP endometrium were suitable for analysis in RIF patients, so we also recruited 14 sample cases in the EPP, LPP, MSP, and LSP groups; in the same way, only 26 cases of MSP endometrium were suitable for analysis in control women, so we also recruited 26 sample cases in the EPP, LPP, ESP, and LSP groups.
Tiam1/Rac1 SIGNALS, miR-22, EMBRYO IMPLANTATION saline containing 5% nonfat dry milk for 24 h at room temperature. Western blot analysis was then carried out by probing PVDF membranes with antibodies against Tiam1 (C-16) and Rac1 (C-11) (1:500 dilutions; Santa Cruz Biotechnology, Inc.). The internal standards of b-actin and glyceraldehyde phosphate dehydrogenase (GAPDH) were used in the Western blot (Shanghai Yingjun Biological Technology & Services Co., Ltd.). Bands were detected by incubation with horseradish peroxidase-conjugated secondary antibody, detected by the enhanced chemiluminescence detection system, and quantified with a computer using the Image-Pro-Plus 6.0 Image program software. All experiments were performed in triplicate. Loading was corrected by the ratio between the detected protein values and the value of the corresponding b-actin protein and was expressed as arbitrary units.
Immunohistochemical Analysis
Mouse and patient uterus tissue sections were prepared and the endogenous peroxidase activity was quenched by incubation with 3% H 2 O 2 for 15 min and followed by a rinse in PBS. Antigen retrieval was achieved with hot repair in 10 mmol/L of citrate buffer. Then the sections were incubated with rat anti-mouse or human TIAM1 and RAC1 antibodies. For control slides, substitution of preimmune serum for the primary antibody was utilized as negative control. After incubation with biotinylated goat anti-Rat IgG, the chromogenic reaction was carried out with diaminobenzidine and the reaction was terminated with water. Slides were counterstained with hematoxylin before permanent mounting and then evaluated by light microscope. Claybank coloration was positive.
Statistical Analysis
All data analysis in this study was performed by SAS 9.1.3 statistical software (SAS Institute Inc.). The t-test was conducted to detect significant differences between patients with RIF and control women and between the pregnant and pseudopregnant mice. Univariate ANOVA was performed to detect significant differences at different time points within each group or differences among two or more groups. Post hoc pairwise comparisons were conducted when ANOVA analysis found significant differences. The results are shown with means 6 standard deviations. A P value of ,0.05 was considered statistically significant. Sidak t-test or Bonferroni t-test was applied to pairwise comparisons, and the test level a was adjusted when the two methods were used.
RESULTS
Tiam1/Rac1 Signal Expression Peaked During the Embryo Implantation Window for Pregnant Mice, Accompanied by miR-22 Decrease
We first evaluated miR-22, Tiam1, and Rac1 expression trends in the endometria during the embryo implantation window in pregnant and pseudopregnant mice. Endometrial Tiam1 and Rac1 mRNA and protein gradually increased with the days of pregnancy and reached maximum levels on the fourth day of pregnancy and then decreased on the fifth, sixth, and seventh days of pregnancy, shown in Figure 2 . However, miR-22 in early-pregnancy mice gradually decreased from the second to the fourth day of pregnancy, was lowest during the embryo implantation window (in the evening of the fourth day of pregnancy), and then gradually increased on the sixth and seventh days of pregnancy, and there was no significant difference between the fourth and fifth days of pregnancy. In pseudopregnancy mice, the expression trends of miR-22, Tiam1, and Rac1 mRNA and protein on endometria before the implantation window were similar to those in pregnant mice, but on the sixth and seventh day after the implantation window, a sharp rise in miR-22 expression and obvious decrease in Tiam1 and Rac1 mRNA and protein were detected, which were fairly close to the levels in the nonpregnant group. There were statistical differences in the expression of miR-22, Tiam1, and Rac1 mRNA and their protein between the pregnant and pseudopregnant mouse groups on the fifth, sixth, and seventh days, P , 0.05, Figure 2 .
TIAM1/RAC1 Signals and miR-22 Expression Trends in the Endometria During the Embryo Implantation Window in Women Were Similar to Those of Pregnant Mice
The characteristics of all subjects in the clinical study are presented in Tables 3 and 4 . There were no statistical differences between the two groups of patients in terms of basic characteristics, including age and BMI. The profiled genes and their protein expressions in endometrium in all subjects are shown in Figure 3 . Compared with the proliferation phase, endometrial TIAM1 and RAC1 mRNA and protein expression were in all subjects up-regulated in the secretion phase, accompanied with miR-22 down-regulation, P , 0.005. In the control women, TIAM1 and RAC1 mRNA and protein expression were obviously increased in the secretion phase, especially reaching the highest level in the MSP, P , 0.005; endometrial miR-22 was much lower during the secretion phase, and the lowest point of its expression was seen in the MSP group; and miR-22 expression was maximal in LPP when E 2 concentration peaked, shown in Figure 3 . In order to better define whether or not miR-22, TIAM1, and RAC1 affected embryo implantation in patients with RIF, we first evaluated the gene expression differences in the endometria in the natural menstrual cycle between patients with RIF and control women. There were no significant differences in miR-22, TIAM1, or RAC1 mRNA and protein expression in the EPP and LPP groups between the RIF and control group. Although the changing patterns of miR-22, TIAM1, and RAC1 expression in the secretion phase in the two groups were similar, the range of their expression in the implantation window of the endometrium in the RIF group was significantly smaller than in the control group. Compared with control women, endometrial miR-22 was evidently higher during the implantation window in the RIF group, whereas TIAM1 and RAC1 mRNA and protein expression were much lower, P , 0.05, as shown in Figure 3 . The immunolocalization analysis of TIAM1 and RAC1 protein over implantation window endometrium showed that TIAM1 and RAC1 protein expressed prominently in the stromal cells and glandular epithelium and slightly in luminal epithelium cells in MSP endometrium in control women, shown in Figure 4 . TIAM1 and RAC1 protein in endometrium of women with RIF showed low expression in 
Gene
Name Sequence
Human-TIAM1 Sense We probed further whether miR-22 and Tiam1/Rac1 signals in the endometrium were related to embryo implantation in mice. The hard GFP signals were detected by fluorescence microscope on the seventh day after lentiviral injection of uterus in vivo and indicated success of lentiviral transfection, shown in Figure 5A . Compared with the two control groups, on the seventh day after LV3-Tiam1-shRNA injection of uterus, Tiam1 mRNA was decreased by 2.66 and 2.82 times, respectively; miR-22 was not significantly changed. Micro-RNA-22 was increased by 3.17 and 3.31 times after LV3-miR-22 injection of uterus, and Tiam1 mRNA expression levels decreased by 1.89 and 2 times, respectively. Additionally, compared with the two control groups, Rac1 mRNA and protein were all decreased in the Tiam1-siRNA group and the miR-22 overregulation group, Figure 5B . MicroRNA-22 overexpression or Tiam1 RNAi in the endometrium inhibited the Tiam1/Rac1 signals in mice.
To provide definite evidence on whether miR-22 upregulation and Tiam1/Rac1 signal down-regulation in the endometrium during the implantation window were related to embryo implantation failure, we generated the fertilized mouse model of miR-22 overexpression and Tiam1 RNAi in the endometrium and then observed embryo implantation numbers. After fertilization of transfected female mice, compared with the Tiam1-siRNA group and the two control groups, endometrial miR-22 in the LV3-miR-22 group in the evening of the fourth day of pregnancy was increased 4.42, 4.33, and 4.6 times, respectively. Tiam1 mRNA and protein were both decreased in the Tiam1-siRNA group and the LV3-miR-22 group, compared with the LV3-NC group (decreased 3.82 and
Endometrial miR-22, Tiam1, and Rac1 mRNA and protein expression in pregnant and pseudopregnant mice. A, B, and C) MicroRNA-22, Tiam1, and Rac1 mRNA expression were measured in pregnant or pseudopregnant mouse endometrium respectively using qRT-PCR. D) TIAM1 and RAC1 protein expression were detected in pregnant or pseudopregnant mouse endometrium respectively by Western blotting and using b-actin as a loading control. TIAM1/b-actin (E) and RAC1/b-actin (F) quantitative data were generated by ImageJ 1.43u. Day 0: no pregnant mice, Day 2, Day 3. . .Day 7 refers to the day of pregnancy or pseudopregnancy. There were seven mice in genuine pregnancy or pseudopregnancy respectively at each indicated time point. Tiam1 and Rac1 mRNA and protein gradually increased with days of pregnancy or pseudopregnancy, reached maximum levels on the fourth day of pregnancy or pseudopregnancy, then decreased on the fifth, sixth, and seventh days of pregnancy. MicroRNA-22 expression gradually decreased from the second to the fourth day of pregnancy or pseudopregnancy, and was lowest during the embryo implantation window (in the evening of the fourth day of pregnancy), and then increased on the sixth and seventh days. Data are presented as mean 6 SD. *P , 0.05, there was a statistical difference between genuine pregnancy and pseudopregnancy mice at the same time; #P , 0.0024 versus any time in pregnant mice; 'P , 0.0024 versus any time in pseudopregnancy mice; test level was adjusted by the Sidak method. Figure 6A . After fertilization, endometrial Rac1 mRNA and protein during the implantation window in the LV3-miR-22 and Tiam1-siRNA group were significantly lower in the transfected mice than in the two control groups, P , 0.0083, shown in Figure 6A . Immunolocalization analysis showed TIAM1 and RAC1 protein mainly located in the stroma cells and glandular epithelium in the endometrium during the implantation window in the two control mouse groups, and only faint signals of TIAM1 and RAC1 protein were detected in the stroma cells and glandular epithelium in the Tiam1-siRNA and LV3-miR-22 transfected groups, shown in Figure  7 .
FIG. 3. Endometrial miR-22, Tiam1
, and Rac1 mRNA and protein expression in patients with RIF and control women during the natural menstrual cycle. A, B and C) MicroRNA-22, TIAM1, and RAC1 mRNA expression were measured in endometrium during the natural menstrual cycle of RIF patients or control women respectively using qRT-PCR. D) TIAM1 and RAC1 protein expression were detected in in endometrium during the natural menstrual cycle of RIF patients or control women respectively by Western blotting and using b-actin as a loading control. TIAM1/b-actin (E) and RAC1/b-actin (F) quantitative data were generated by ImageJ 1.43 u. G) Endometrial miR-22, TIAM1, and RAC1 mRNA expression plot during the whole menstrual cycle of control women and serum E 2 and P density plot. There were 26 control women and 14 RIF at each indicated phase of the menstrual cycle. Data in the bar graphs represent the mean 6 SD. *P , 0.0024 versus any phase of the menstrual cycle in the control group; #P , 0.0024 versus any phase of menstrual cycle in RIF group, test level was adjusted by the Sidak method; 'statistical difference in the same phase in the natural menstrual cycle between patients with RIF and control women. 
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After fertilization, the number of embryo implantations was significantly diminished in the Tiam1-shRNA injection group and the LV3-miR-22 group of the transfected female mice, compared with the two control groups, P , 0.0083. And there was no statistical difference of the embryo implantation number between the Tiam1-siRNA group and the LV3-miR-22 group, shown in Figure 6B .
miR-22 and Tiam1/Rac1 Signal Expression in the Endometrium Was Regulated by Serum E 2 and P in Mice
To pinpoint whether endometrial miR-22, Tiam1, and Rac1 expression and ovarian hormones were correlated, we analyzed miR-22, Tiam1, and Rac1 expression after administration of E 2 and progestin in ovariectomized mice. It was found that administration of E 2 induced a dose-dependent increase in miR-22 and decrease in Tiam1 and Rac1 mRNA and protein expression in the endometrium; to the contrary, the administration of P induced a dose-dependent increase in Tiam1 and Rac1 mRNA and protein expression and a decrease in miR-22 expression in the endometrium, P , 0.0083, shown in Figure  8 . These data indicated that progestin could adversely affect the regulation of miR-22, Tiam1, and Rac1 by E 2 , as shown in Figure 8 .
Additionally, although there was no statistical difference between E 2 and P concentrations during the embryo implantation window between patients with RIF and control women, the difference in P:E 2 ratio was statistically significant between the two groups of women, shown in Tables 3 and 4 . Notably, the P:E 2 ratio was significantly lower in the RIF group (82.89 6 3.69) than in the control group (97.92 6 4.71), P ¼ 0.0146, shown in Tables 3 and 4 ; the numerical value of E 2 was relatively higher and P was slightly lower during embryo implantation in patients with RIF. Meanwhile, miR-22 expression in the endometrium during the embryo implantation window was increased, and TIAM1 and RAC1 mRNA and protein expression were significantly down-regulated. However, the correlation coefficients by Pearson correlation analysis between miR-22 or TIAM1 and RAC1 mRNA expression and serum E 2 and P concentration demonstrated no statistical significance in the control group women, P , 0.05. And the correlation coefficients of miR-22, TIAM1, and RAC1 mRNA against P:E 2 were À0.24860 (P ¼ 0.2906), 0.15883 (P ¼ 0.5036), and 0.12699 (P ¼ 0.5937), respectively, all P . 0.05, also demonstrating no statistical significance.
DISCUSSION
Embryo implantation requires RAC1-dependent endometrial stroma cell migration in humans [9] , and Rac1 has been demonstrated to be activated by Tiam1 and then to promote cytoskeleton reorganization and cell migration and motility [10, 13, 33, 34] . TIAM1 was shown to regulate embryo implantation in mice [6] [7] [8] . Moreover, miR-22 has been reported to specifically inhibit the expression of Tiam1 [16, 17] . This study evaluated the impact of endometrial miR-22 and Tiam1/Rac1 signals on embryo implantation in mice and the impact of serum E 2 and P concentration on miR-22, Tiam1, and Rac1 expression in endometrium. Similarities between mice and human beings in the molecular mechanisms of embryo implantation suggest that a mouse model might provide some insights for embryo implantation in humans [5, 35] . This study also assessed the expression of miR-22 and Tiam1/Rac1 signals in the endometria during the natural menstrual cycle in infertile women with RIF (who had normal uterine cavity without intrauterine adhesion, inflammation, or deformation and had undergone transplantation failure of more than six high-quality embryos).
Rac1, activated by Tiam1, has been demonstrated to have multiple biologic effects, including promoting cytoskeleton reorganization and cell migration and motility, extracellular matrix reconstruction, cell adhesion, regulating cell morphological transformation, signal transduction, and angiogenesis in some cells [10] [11] [12] [13] [14] [15] 34] . These processes are also very important for stromal cell decidualization and endometrium receptivity attainment and embryo implantation. Our previous study showed that Tiam1 in the endometrium plays an important role in embryo implantation in mice, and the number of implantation sites was greatly decreased by intrauterine injection with anti-TIAM1 polyclonal antibodies before embryo implantation in mice [6] [7] [8] . Embryo invasion into human endometrial stroma cells transfected with RAC1 siRNAs Tiam1/Rac1 SIGNALS, miR-22, EMBRYO IMPLANTATION was inhibited significantly in vitro [9] . Endometrial stroma cells were motile during embryo implantation and the spreading and invasion of the embryonic trophoblast required RAC1-dependent migration and motility of maternal endometrium stromal cells [9] . The specific expression patterns of TIAM1 and RAC1 in the endometrium during the menstrual cycle in humans and early-pregnancy mice in this study and in other published studies suggest that increasing expression of Tiam1/Rac1 signals during the implantation window of the endometrium might be involved in regulating stromal cell migration and motility by altering organization of the actin cytoskeleton and then facilitating embryo implantation in both humans and mice.
The latest research shows that miR-22 negatively regulates the function of TIAM1 protein by targeting the Tiam1 mRNA 3 0 UTR, inhibiting Tiam1 mRNA transcription and translation, and then interfering with cell migration and motility [16, 17] . The guanine nucleotide exchange factor Tiam1, as an activator of Rac1, can then regulate cell migration, motility, adhesion, angiogenesis, and dynamic cellular processes in a variety of cell types [14, 32, 33] . The spreading and invasion of human embryonic trophoblasts requires RAC1-dependent motility of , and LV3-Tiam1-shRNA groups, and it was preliminarily indicated that lentiviral transfection was successful. B) MicroRNA-22, Tiam1, Rac1, and protein mRNA expression in the endometrium on the seventh day after lentiviral transfection in four groups as indicated. There were five mice in each group. Compared with the two control groups, Tiam1 mRNA was decreased and miR-22 was not significantly changed in the LV3-Tiam1-shRNA group, and miR-22 was increased and Tiam1 mRNA expression was decreased in the LV3-miR-22 group, respectively. Additionally, compared with the two control groups, Rac1 mRNA and protein were all decreased in the Tiam1-siRNA group and the miR-22 overregulation group. The data in the bar graphs represent the mean 6 SD. *P , 0.0083, means that there was a statistical difference in multiple comparison of four groups or between two bars marked by transverse line; test level was adjusted by Bonferroni method.
maternal endometrium stromal cells [9] .The decrease in Tiam1/ Rac1 signals during the implantation window in the endometrium for fertilized transfected mice with miR-22 overexpression or Tiam1 RNAi might suggest that overexpression of miR-22 inhibits the transcription and translation of Tiam1 and then prevents activation of Rac1. This may in turn decrease stromal cell motility and migration, matrix protein hydrolyzation, endometrium receptivity attainment, and embryo implantation. In this study, it appears that down-regulation of TIAM1/RAC1 signals during the implantation window in the endometria of patients with RIF accompanied with increased miR-22 might contribute to implantation failure, and the higher expression of miR-22 during the implantation window in the endometria in these patients might directly or indirectly down-regulate the transcription and translation of TIAM1, interfere with TIAM1/ RAC1 signals, and then subsequently affect embryo implantation.
It is well known that periodic changes of the endometrium, receptivity, and embryo implantation are subtly regulated by ovary hormones (mainly E 2 and P) and a great number of genes and molecules [36] [37] [38] [39] [40] . Dynamic changes in ovarian E 2 and P secretion regulate endometrial function and blastocyst implantation. It has also been reported that miR-22 targeted and negatively regulated the downstream gene ERa and then interfered with E 2 signaling and function in some E 2 -dependent tumor cells [17, 37, 38, 41] . In this study, the ovariectomized FIG. 6. Endometrial overexpression of miR-22 down-regulated Tiam1/Rac1 signaling during embryo implantation in mice and then inhibited embryo implantation. A) MicroRNA-22, Tiam1, and Rac1 mRNA and their protein expression levels in the endometrium during embryo implantation after fertilization of lentiviral transfected mice. Control, no intervention, n ¼ 5; LV3-NC, lentiviral transfection control group; LV3-miR-22, miR-22 overexpression by lentiviral transfection group, LV3-Tiam1-shRNA, Tiam1 RNAi by lentiviral transfection. There were five mice in each group. Data in the bar graphs represent the mean 6 SD. *P , 0.0083, statistical difference compared with any other group in the four groups or between two bars marked by transverse line; test level were adjusted by Bonferroni method. B) Representative images of embryo implantation and development (using trypan blue for staining) after fertilization of lentiviral-transfected mice with overexpression of miR-22 or Tiam1 RNAi. 1) Control group with no intervention. 2) Lentiviral transfection group with LV3. 3) MicroRNA-22 overexpression by lentiviral transfection group. 4) Tiam1 RNAi by lentiviral transfection. 5) Total embryo implantation after fertilization in four groups as indicated. The numbers of embryo implantation sites were significantly diminished after miR-22 overexpression or Tiam1 RNAi lentiviral transfection in the endometrium, compared with the control group and the negative control empty lentiviral transfection group. Data in the bar graphs represent the mean 6 SD. *P , 0.0083, statistical difference between two bars that are marked by transverse line; test level was adjusted by Bonferroni method.
Tiam1/Rac1 SIGNALS, miR-22, EMBRYO IMPLANTATION mice model experiment results demonstrate that miR-22, Tiam1, and Rac1 expression were dose dependent with E 2 and P. It was also found that miR-22 expression was highest in LPP endometria during the natural menstrual cycle when E 2 concentration peaked in control women in this study whereas TIAM1 and RAC1 mRNA and protein expression reached the maximum levels in MSP when P concentration peaked, accompanied with lowering of miR-22, which was consistent with the results of the animal experiments and might suggest that miR-22 expression in the endometrium during the menstrual cycle in humans might also be regulated by serum E 2 . On the other hand, P might reverse the effect of E 2 on miR-22, TIAM1, and RAC1 expression in the endometrium.
The administration of E 2 induced a dose-dependent increase in miR-22 expression and a decrease in Tiam1 and Rac1 expression in the endometrium in ovariectomized mice, but P had the reverse effect in our study. This is consistent with a previous study that showed implantation was inhibited by relatively high levels of E 2 in mice, this effect was overcome by concomitant administration of P, and there was a significant dose-response-related interaction of P with E 2 [42] . Although there was no statistical difference in E 2 and P concentrations in the two groups, the numerical value of E 2 was relatively higher and P was slightly lower in the RIF group, and the P:E 2 ratio was significantly lower in the RIF group. In our study, although the expressions of TIAM1 and RAC1 in the endometrium during the implantation window were also increased, and accompanied with decreased miR-22 in the RIF group, the ranges of miR-22, TIAM1, and RAC1 expression in the RIF group were significantly smaller than those in the control group. The above results in this study suggest that the decreased P:E 2 ratio during the implantation window in patients with RIF might be one of the main reasons for the abnormal expression of miR-22, TIAM1, and RAC1 in the endometrium. The expression of miR-22 in the endometrium during the implantation window might be up-regulated by slightly increased serum E 2 and lower P concentration in RIF, and then overexpression of miR-22 inhibits TIAM1/RAC1 signals and finally interferes with embryo implantation in patients with RIF. This is consistent with the findings from Gidley-Baird et al. [42] and Keltz et al. [43] that the P:E 2 ratio was a better predictor of implantation failure than the absolute level of either hormone. The above results also suggest that reasonable control of the serum E 2 and P ratio during the embryo implantation window is necessary for the normal expression of certain genes in the endometrium and embryo implantation during a cycle of clinical ART treatment.
However, without embryo stimulation in pseudopregnancy mice, the early decidualization reaction disappeared very quickly, and endometrium morphology in the late phase of pseudopregnancy mice was similar to that of no pregnancy [21, [44] [45] [46] . Endometrial miR-22, Tiam1, and Rac1 expressions in pseudopregnancy mice changed sharply after the implantation window and they were similar to that in nonpregnant mice in this study. Given all the results discussed above, miR-22, Tiam1, and Rac1 expression and function in the endometrium might be regulated not only by ovary hormones but also embryo signals and other molecules or factors, as shown in previous studies that showed certain cytokines are embryo dependent and play important functions during embryo implantation [9, 45] .
FIG. 7.
Immunolocalization of TIAM1 and RAC1 protein on transfected mice endometria on the fourth day of pregnancy. Control, normal pregnant group without any intervention; LV3, LV3 control group; LV3-miR-22, miR-22 overexpressed by lentiviral injection group; LV3-Tiam1-shRNA, Tiam1 RNAi by lentiviral injection group; Le, luminal epithelium; Ge, glandular epithelium; S, stromal cell. Negative control was control sections substituting preimmune sera for the primary antibodies and that did not produce any positive immunostaining signals. Strong signals for TIAM1 and RAC1 proteins in the endometria were detected on Day 4 of pregnancy in the two control groups; TIAM1 and RAC1 protein mainly localized in stroma cells and gland epithelium in endometrium over implantation window in normal pregnant mice; only faint signals of TIAM1 and RAC1 protein were detected in glandular epithelium and very faint or few signals in stroma cells in the miR-22 overexpressed and Tiam1-siRNA groups. Bar ¼ 200 lm. "   FIG. 8 . MicroRNA-22, Tiam1, and Rac1 expression in the endometrium in ovariectomized mice after administration of E 2 and progestin. A) MicroRNA-22, Tiam1, and Rac1 mRNA and protein expression in the endometrium in ovariectomized mice after administration of Progynova (estradiol valerate) with different dosages. B) MicroRNA-22, Tiam1, and Rac1 mRNA and protein expression in the endometrium of ovariectomized mice after administration of progestin (medroxyprogesterone acetate tablets) with different dosage. C) MicroRNA-22, Tiam1, and Rac1 mRNA and protein expression in the endometrium of ovariectomized mice after administration of a combination of E 2 and progestin (estradiol valerate and medroxyprogesterone) with different dosages; there were 10 mice in each group. These data show that the administration of E 2 induced a dose-dependent increase in miR-22 and a decrease in Tiam1 and Rac1 mRNA and protein expression in the endometrium; to the contrary, the administration of P induced a dose-dependent increase in Tiam1 and Rac1 mRNA and protein expression and a decrease in miR-22 expression in the endometrium. Data in the bar graphs represent the mean 6 SD. *P , 0.0083, statistical difference compared with any other group in four different dosage groups or between two bars marked by transverse line; test level was adjusted by the Sidak method.
Tiam1/Rac1 SIGNALS, miR-22, EMBRYO IMPLANTATION
In conclusion, the findings in the present study may have important implications for understanding the abnormal expression of miR-22, TIAM1, and RAC1 mRNA and protein in the endometrium during the implantation window that might be involved in the failure of embryo implantation in patients with RIF. However, the failure of embryo implantation in patients with RIF is complex and cannot be determined by dysregulation of any one gene or one protein, and further investigations should be performed to ascertain the exact regulation mechanism and function of miR-22 and TIAM1/RAC1 signals in the menstrual cycle and during embryo implantation. In addition, study of human endometrial cells in vitro should be done to understand the gene function and regulation mechanisms during human embryo implantation.
